Persistence of Risk for Venous Thromboembolism After Resection for Colorectal Cancer
A team of researchers conducted a meta-analysis to determine the variation in incidence of venous thromboembolism following resection for colorectal cancer.
A team of researchers conducted a meta-analysis to determine the variation in incidence of venous thromboembolism following resection for colorectal cancer.
A team of investigators conducted a prospective cohort study to assess the impact of population-based FIT screening on CRC-related mortality and advanced-stage disease.
The researchers’ goal was to determine which dimensions of smoking increase the risk for gastric intestinal metaplasia, which is a precursor lesion of gastric cancer.
Investigators compared the outcomes of patients who received pancreatic enzyme replacement therapy (PERT) with those who did not.
A team of researchers conducted a multicenter, randomized study to determine the best strategy for offering population-wide screening for colorectal cancer.
LEAP-005 investigators tested the safety and efficacy of combination lenvatinib and pembrolizumab in 32 patients with previously treated advanced non–microsatellite instability-high (MSI-H)/mismatch repair proficient (pMMR) colorectal cancer (CRC).
A team of investigators conducted a systematic literature search to assess the cumulative incidence of disease recurrence in patients who underwent local endoscopic resection of early invasive colorectal cancer.